InsiderClue
Stocks · Health care · Services-Medical Laboratories

BillionToOne, Inc.

BLLN Clue Score76
United States Fiscal year ends December CIK 0002070849 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

48
Insider
Date
Role
Action
Shares
Price
Amount
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
23
$113.17
$2.60K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
208
$112.01
$23.30K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
633
$111.14
$70.35K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
2,389
$110.31
$263.52K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
3,234
$109.15
$353.00K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
2,450
$108.39
$265.54K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
1,063
$107.33
$114.09K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
100
$113.17
$11.32K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
300
$112.19
$33.66K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
1,130
$110.77
$125.17K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
1,992
$110.13
$219.38K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
3,241
$109.04
$353.41K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
2,320
$108.24
$251.11K
David Tsao
2 Nov 2026
Chief Technology Officer
Sold after exercise
917
$107.31
$98.41K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise indirect
2,667
$113.17
$301.82K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise indirect
2,667
$113.17
$301.82K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
200
$112.39
$22.48K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
411
$111.03
$45.63K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
2,223
$110.35
$245.31K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
2,451
$109.11
$267.44K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
2,075
$108.43
$224.99K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
974
$107.34
$104.55K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
536
$112.44
$60.27K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
1,117
$110.98
$123.96K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
3,803
$110.29
$419.43K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
5,720
$109.08
$623.93K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
4,009
$108.25
$433.96K
Oguzhan Atay
2 Nov 2026
Chairman and CEO
Sold after exercise
1,482
$107.31
$159.04K
Bosch John Roderick ten
2 Nov 2026
SVP of Laboratory Operations
Sold on a plan
1,417
$113.17
$160.36K
Bosch John Roderick ten
2 Nov 2026
SVP of Laboratory Operations
Sold on a plan
1,417
$113.17
$160.36K
Oguzhan Atay
28 Oct 2026
Chairman and CEO
Sold after exercise indirect
2,667
$118.00
$314.71K
Oguzhan Atay
28 Oct 2026
Chairman and CEO
Sold after exercise
8,333
$118.00
$983.29K
Oguzhan Atay
15 Oct 2026
Chairman and CEO
Sold after exercise
133
$102.78
$13.67K
Oguzhan Atay
15 Oct 2026
Chairman and CEO
Sold after exercise
980
$101.79
$99.75K
Oguzhan Atay
15 Oct 2026
Chairman and CEO
Sold after exercise
1,276
$100.60
$128.37K
Oguzhan Atay
15 Oct 2026
Chairman and CEO
Sold after exercise
1,861
$99.84
$185.81K
Oguzhan Atay
15 Oct 2026
Chairman and CEO
Sold after exercise
900
$98.43
$88.59K
Oguzhan Atay
14 Oct 2026
Chairman and CEO
Sold after exercise indirect
2,667
$98.00
$261.37K
Oguzhan Atay
14 Oct 2026
Chairman and CEO
Sold after exercise
100
$99.00
$9.90K
Oguzhan Atay
14 Oct 2026
Chairman and CEO
Sold after exercise
3,083
$98.32
$303.12K
Thomas P. Lynch
13 Oct 2026
See Remarks
Exercised, kept
2,000
$8.65
$17.30K
Oguzhan Atay
12 Oct 2026
Chairman and CEO
Sold after exercise indirect
2,667
$97.61
$260.33K
Oguzhan Atay
12 Oct 2026
Chairman and CEO
Sold after exercise
1,521
$96.39
$146.61K
Oguzhan Atay
12 Oct 2026
Chairman and CEO
Sold after exercise
3,869
$94.61
$366.06K
Oguzhan Atay
12 Oct 2026
Chairman and CEO
Sold after exercise
6,763
$93.65
$633.33K
Oguzhan Atay
12 Oct 2026
Chairman and CEO
Sold after exercise
2,553
$93.05
$237.55K
Oguzhan Atay
12 Oct 2026
Chairman and CEO
Sold after exercise
1,961
$91.57
$179.57K
Thomas P. Lynch
8 Oct 2026
See Remarks
Exercised, kept
8,000
$8.65
$69.20K

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 44
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 88,334
History held since 10 Nov 2025